| Bethany Martin, | |
|
141 N Forge St, Akron, OH 44304-1407 | |
| (330) 375-3000 | |
| Not Available |
| Full Name | Bethany Martin |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 141 N Forge St, Akron, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407431950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.007192 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bethany Martin, 28891 State Route 172, Kensington, OH 44427-9732 Ph: (330) 692-0239 | Bethany Martin, 141 N Forge St, Akron, OH 44304-1407 Ph: (330) 375-3000 |
News Archive
Treatment with tenofovir disoproxil fumarate elicits sustained virological responses and exhibits a favourable safety profile in a diverse population of patients with chronic hepatitis B virus infection, shows a French routine clinical practice study.
Asklepios BioPharmaceutical, Inc., a privately-owned clinical-stage biotechnology company, announced today it has entered into a patent license agreement with Pfizer, Inc. granting Pfizer access to certain proprietary gene-delivery platform technologies developed by AskBio, for use in developing novel therapies for patients with Hepatitis C virus (HCV).
Autosomal-dominant polycystic kidney disease (ADPKD) is one of the most common genetic disorders, affecting one in every 1,000 people and responsible for up to ten percent of patients on dialysis worldwide. The disease is characterized by the development of cysts that lead to progressive kidney failure and necessitate dialysis or a kidney transplant in most patients aged around fifty. Moreover, the persistent cyst growth causes high blood pressure and painful complications.
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio, including PF-00299804 an investigational, oral, pan-HER inhibitor; and crizotinib, an investigational, oral, first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK, at the International Association for the Study of Lung Cancer's 14th World Conference on Lung Cancer, July 3-7 in Amsterdam, The Netherlands.
The Cancer Prevention and Research Institute of Texas recently presented a $300,000 check to the University of North Texas Health Science Center. The check was accepted by the UNT Health Science Center Provost Thomas Yorio, Ph.D., and Richard Kurz, Ph.D., dean of the School of Public Health.
› Verified 6 days ago
Margaret S Sfiligoj, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-9634 Fax: 330-375-3769 | |
Brittany Johnson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1622 E Turkeyfoot Lake Rd Ste 201, Akron, OH 44312 Phone: 330-776-4444 Fax: 330-776-4449 | |
Brittany Conner, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3975 Embassy Pkwy, Akron, OH 44333 Phone: 330-670-4242 | |
Mrs. Lara Renee Young, P.A.-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 150 Cross St, Akron, OH 44311 Phone: 330-996-9141 | |
Mr. Kodi Veale, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3975 Embassy Pkwy, Akron, OH 44333 Phone: 330-668-4040 Fax: 330-668-4078 | |
Eric Bendel, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Christy A. Mackay, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Park West Blvd, Suite 200, Akron, OH 44320 Phone: 330-869-9777 Fax: 330-865-6011 |